VRTX
Vertex Pharmaceuticals IncData: 2026-10-23
Quick Stats
Oct 23, 202657.6
AI Score
HOLD0.71
Volume Ratio
Nov 02, 2026
Next Earnings
16
+ve Days (30d)
14
-ve Days (30d)
VRTX Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
VRTX Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
VRTX Options - Sort by Max open Interest (near term)
24th October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
VRTX Daily Out of Money Options - Sort by Max open Interest (near term)
24th October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
VRTX Daily In the Money Options - Sort by Max open Interest (near term)
24th October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
VRTX Most Active Options by Volume(near term)
24th October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
VRTX Technical Chart Pro Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
VRTX Stock Summary
Last updated Oct 23, 2026
VRTX is currently trading at $523.93, positioned above its 200-day moving average of $477.37, indicating a long-term uptrend. The stock has a 52-week range of $403.16 to $560.25.
Technical Analysis: The 50-day moving average stands at $522.71, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 55.033, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.105, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates VRTX at 57.6/100 with a HOLD recommendation.
VRTX (Vertex Pharmaceuticals Inc) Indicators
Last updated Oct 23, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 55.033 |
| CMF (20) | -0.105 |
| ROC (10) | 2.715 |
| ADX (14) | 19.218 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.976 |
| AROONOSC (14) | 50.0 |
| WILLAMS %R (14) | -25.833 |
| MFI (14) | 67.367 |
VRTX Candlestick Patterns
No validated candlestick patterns fired for VRTX in the last 10 sessions — that's normal. Only the ~15 patterns with a backtested edge (out of 60 textbook patterns) are tracked here.
Vertex Pharmaceuticals Inc is above both the 50 Day and 200 Day SMA which is considered Bullish.
VRTX Moving Averages Analysis
Vertex Pharmaceuticals Inc has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Oct 23, 2026
Vertex Pharmaceuticals Inc has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Oct 23, 2026
VRTX (Vertex Pharmaceuticals Inc) Simple Moving Averages
Moving Averages are last updated Oct 23, 2026
| Days | MA |
|---|---|
| 10 | 509.94 |
| 20 | 510.64 |
| 30 | 512.52 |
| 50 | 522.71 |
| 100 | 501.3 |
| 200 | 477.37 |
VRTX Fundamental Analysis
| P/E (Forward) | 24.0964 |
| P/E (Trailing) | 30.5462 |
| Market Cap ($) | 135.6 billion |
| Earnings/Share ($) | 17.52 |
| Net Profit Margin (%) | 0.35 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 17.8763 |
| EPS Estimate Next Year ($) | 20.4183 |
| WallStreet Target Price ($) | 571.46 |
| Most Recent Quarter |
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.